InvestorsHub Logo
Followers 79
Posts 1668
Boards Moderated 0
Alias Born 08/26/2008

Re: None

Wednesday, 10/29/2014 3:08:56 PM

Wednesday, October 29, 2014 3:08:56 PM

Post# of 499
Another CT Order

SECURITIES AND EXCHANGE COMMISSION
October 29, 2014
ORDER GRANTING CONFIDENTIAL TREATMENT
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Omeros Corporation
File No. 001-34475 - CF#31482
_____________________
Omeros Corporation submitted an application under Rule 24b-2 requesting
confidential treatment for information it excluded from the Exhibits to a Form 10-Q filed
on August 11, 2014.
Based on representations by Omeros Corporation that this information qualifies as
confidential commercial or financial information under the Freedom of Information Act,
5 U.S.C. 552(b)(4), the Division of Corporation Finance has determined not to publicly
disclose it. Accordingly, excluded information from the following exhibits will not be
released to the public for the time periods specified:
Exhibit 10.1 through May 12, 2017
Exhibit 10.2 through August 4, 2016
For the Commission, by the Division of Corporation Finance, pursuant to
delegated authority:
Brent J. Fields



Half and Half Bavituximab and (?)
So the music plays on!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OMER News